Kabat numbering scheme (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Kabat numbering scheme" in English language version.

refsWebsite

Global rank English rank

low place

low place

4^th place

4^th place

low place

low place

2^nd place

2^nd place

bioinf.org.uk (Global: low place; English: low place)

"A description of the Kabat numbering scheme". Bioinf.org.uk. Retrieved 2013-07-26.
"bioinf.org.uk - Prof. Andrew C.R. Martin's group at UCL". www.bioinf.org.uk. Retrieved 2023-02-22.

doi.org (Global: 2^nd place; English: 2^nd place)

Wu, Tai Te; Kabat, Elvin A. (1970-08-01). "An Analysis of the Sequences of the Variable Regions of Bence Jones Proteins and Myeloma Light Chains and Their Implications for Antibody Complementarity" (PDF). Journal of Experimental Medicine. pp. 211–250. doi:10.1084/jem.132.2.211. PMC 2138737. PMID 5508247. Retrieved 2023-02-22.

nih.gov (Global: 4^th place; English: 4^th place)

ncbi.nlm.nih.gov

Wu, Tai Te; Kabat, Elvin A. (1970-08-01). "An Analysis of the Sequences of the Variable Regions of Bence Jones Proteins and Myeloma Light Chains and Their Implications for Antibody Complementarity" (PDF). Journal of Experimental Medicine. pp. 211–250. doi:10.1084/jem.132.2.211. PMC 2138737. PMID 5508247. Retrieved 2023-02-22.

pubmed.ncbi.nlm.nih.gov

Wu, Tai Te; Kabat, Elvin A. (1970-08-01). "An Analysis of the Sequences of the Variable Regions of Bence Jones Proteins and Myeloma Light Chains and Their Implications for Antibody Complementarity" (PDF). Journal of Experimental Medicine. pp. 211–250. doi:10.1084/jem.132.2.211. PMC 2138737. PMID 5508247. Retrieved 2023-02-22.

rupress.org (Global: low place; English: low place)

Wu, Tai Te; Kabat, Elvin A. (1970-08-01). "An Analysis of the Sequences of the Variable Regions of Bence Jones Proteins and Myeloma Light Chains and Their Implications for Antibody Complementarity" (PDF). Journal of Experimental Medicine. pp. 211–250. doi:10.1084/jem.132.2.211. PMC 2138737. PMID 5508247. Retrieved 2023-02-22.